HOME >> BIOLOGY >> NEWS
Max Planck researchers make a breakthrough in plant stem cell research

Totipotent stem cells allow plants to build new organs throughout their whole life. But it has been unclear how hormones and genetic factors work together to prevent plants from having growth that is either stunted, or uncontrolled and tumor-like. Scientists from the Max Planck Institute for Developmental Biology have now uncovered a feedback mechanism, involving a growth-enhancing hormone and a regulatory protein, which controls the number of stem cells the plant produces. (Nature, December 22, 2005). The results are of great importance for all of stem cell research.

All above ground parts of a plant - leaves, stem, flowers, and seeds - ultimately are derived from cells of a small tissue at the tip of the shoot. Biologists call this tissue the "apical meristem", and it contains totipotent stem cells that are active throughout the life of the plant. Unlike the stem cells of animals, which can only produce specific kinds of tissue after the animal is past its embryonic stage, plant stem cells remain their totipotency and, therefore plants can continue growing over many years, developing new organs.

But this ability comes at a price. If the number of meristematic stem cells increases too quickly, then there could be uncontrolled growth, similar to cancer. On the other hand, if the stem cell pool shrinks too quickly, the plant could have stunted growth. In order to stay alive and reproduce, the plant needs to find the right balance in the number of its stem cells. Two regulatory mechanisms were found to be important for this process. The first involves growth-promoting hormones like auxin and cytokinin, known already for more than half a century. The second involves genetic factors, which were discovered at the University of Tübingen, Germany about a decade ago. Here it was shown that a gene called WUSCHEL has a key influence on how many cells in the apical meristem actually stay stem cells. However, until now, it was unclear how hormones and regulatory
'"/>

Contact: Dr. Jan Lohmann
jan.lohmann@tuebingen.mpg.de
497-071-601-1405
Max-Planck-Gesellschaft
22-Dec-2005


Page: 1 2 3

Related biology news :

1. 454 Life Sciences and Max Planck publish sequence of one million base pairs
2. Max Planck researchers win part of Descartes Research Prize 2005
3. Global commitment of Max Planck researchers
4. Four Max Planck Partner Groups starting in India
5. First Max Planck Partner Institute in China
6. Innovative tagging technique may help researchers better protect fish stocks
7. Penn researchers discover how key protein stops inflammation
8. ASU researchers partner with UOP to make biofuel for military jets a reality
9. Einstein researchers prototype vaccine could provide improved protection against tuberculosis
10. Penn researchers discover pathway that eliminates genetic defects in red blood cells
11. U-M researchers find family of on switches that cause prostate cancer

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Max Planck researchers make breakthrough plant stem cell research

(Date:10/16/2014)... tract infections and worldwide claims the lives of ... Ghent University have succeeded in developing a promising ... , Xavier Saelens (VIB/UGent): "We discovered a ... the development of a novel approach to vaccination ... numerous small children and elderly people." , ...
(Date:10/15/2014)... ,Models of Life, is a non-traditional biophysics textbook and ... book is a journey of discovery into biological systems ... and biological regulation. It is about how our genes ... between the billions of cells in an organism. It ... between principles, which can be found on both large ...
(Date:10/15/2014)... awarded the 44th Rosenstiel Award for Distinguished Work in ... exploring the mechanisms of genomic instability and its implications ... the second alumnus to win the Rosenstiel Award; the ... , Alt is the Charles A. Janeway Professor of ... and an investigator at the Howard Hughes Medical Institute ...
Breaking Biology News(10 mins):New perspectives for development of an RSV vaccine 2New book about life as seen from physics 2Brandeis awards 44th Rosenstiel Award to pioneering geneticist Fred Alt 2
(Date:10/22/2014)... October 21, 2014 The North American ... market North America with analysis and forecast of revenue. ... and is expected to reach $623.6 million by 2018, ... , Browse through the TOC of the North American ... the in-depth analysis provided. This also provides a glimpse ...
(Date:10/22/2014)... Diego, CA (PRWEB) October 22, 2014 ... balances from Sartorius, A & D Weighing, Rice ... Sartorius CPA Semi-Micro Balance . The Sartorius CPA ... for an affordable high-quality, precise, and user-friendly laboratory ... manufacturing of laboratory equipment, their laboratory balances are ...
(Date:10/22/2014)... --  Synthetic Biologics, Inc. (NYSE MKT: SYN), a ... and diseases, announced today that the U.S. Patent and ... a composition of matter patent application that covers the ... This is Synthetic Biologics, first allowed patent application directly ... the Company,s extensive C. difficile patent estate. ...
(Date:10/22/2014)... HONG KONG , Oct. 22, 2014 ... enterprise, announced today that rare disease expert John ... president, research. Dr. McKew brings more than two decades ... at the National Institutes of Health, Wyeth Research and ... McKew will lead aTyr,s efforts to expand and translate ...
Breaking Biology Technology:The North American crystal oscillator market is expected to reach $623.6 million by 2018 - New Report by MicroMarket Monitor 2The North American crystal oscillator market is expected to reach $623.6 million by 2018 - New Report by MicroMarket Monitor 3The North American crystal oscillator market is expected to reach $623.6 million by 2018 - New Report by MicroMarket Monitor 4Pipette.com Launches the Addition of Sartorius CPA Semi-Micro Balance to Their Product Portfolio with Special Promotional Pricing 2Pipette.com Launches the Addition of Sartorius CPA Semi-Micro Balance to Their Product Portfolio with Special Promotional Pricing 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 2Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 3Synthetic Biologics Announces Allowance of Key U.S. Composition of Matter Patent for C. difficile Program 4aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3
Cached News: